Risk profile and prediction of long-term ischemic stroke mortality: A 21-year follow-up in the Israeli ischemic heart disease (IIHD) project

Circulation

Volumn 98, Issue 14, 1998, Pages 1365-1371

  Tanne, David ^a,d   Yaari, Shlomit ^b   Goldbourt, Uri ^c,d  

^a HENRY FORD HOSPITAL   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cerebrovascular disorders; Epidemiology; Mortality; Risk factors

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ETHNIC DIFFERENCE; FEMALE; GENETIC PREDISPOSITION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SOCIOECONOMICS; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 0032491170     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.14.1365     Document Type: Article

References (32)

1. Menotti A, Keys A, Blackburn H, Aravanis C, Dontas A, Fidanza F, Giampaoli S, Karvonen M, Kromhout D, Nedeljkovic S, Nissinen A, Pekkanen J, Punsar S, Seccareccia F, Toshima H. Twenty-year stroke mortality and prediction in twelve cohorts of the Seven Countries Study. Int J Epidemiol. 1990;19:309-315.
2. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M, for the WHO MONICA Project. Stroke incidence, case fatality, and mortality in the WHO MONICA Project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease [published errata appear in Stroke. 1995;26:1504 and 1995;26:2376]. Stroke. 1995;26:361-367.
3. Aho K, Harsmen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular diseases in the community: results of a WHO collaborative study. Bull World Health Org. 1980;58:113-130.
4. WHO MONICA Project. Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project: an ecological study of 18 populations. Stroke. 1997;28:1367-1374.
5. Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L, for the Multiple Risk Factor Interventional Trial Research Group. Risk factors for death from different types of stroke. Ann Epidemiol. 1993;3:493-499.
6. Håheim LL, Holme I, Hjermann I, Leren P. Risk factors of stroke incidence and mortality: a 12-year follow-up of the Oslo Study. Stroke. 1993;24:1484-1489.
7. Rastenyte D, Tuomilehto J, Domarkiene S, Cepaitis Z, Reklaitiene R. Risk factors for death from stroke in middle-aged Lithuanian men: results from a 20-year prospective study. Stroke. 1996;27:672-676.
8. Njølstad I, Arnesen E, Lund-Larsen PG. Body height, cardiovascular risk factors, and risk of stroke in middle-aged men and women: a 14-year follow-up in the Finnmark Study. Circulation. 1996;94:2877-2882.
9. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbot R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease, part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
10. Verschuren WMM, Jacobs DR, Bloemberg BPM, Kromhout D, Mennoti A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Nedeljković S, Nissinen A, Toshima H. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. JAMA. 1995;274:131-136.
11. Goldbourt U, Yaari S, Medalie JH. Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees: a 23-year mortality follow-up in the Israeli Ischemie Heart Disease Study. Cardiology. 1993;82:100-121.
12. Groen JJ, Medalie JH, Neufeld HN, Riss E, Bachrach CA., Mount FW, Smith HA. An epidemiological investigation of hypertension and ischemic heart disease within a defined segment of the adult male population of Israel. Isr J Med Sci. 1968;4:177-194.
13. Department of Health and Human Services. International Classification of Diseases, 9th Revision. Clinical Modification (ICD-9-CM), 3rd edition, vol. 1. DHHS Publication No. (PHS) 89-1260, 1989.
14. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field studies. Bull World Health Organ. 1962;27:645-648.
15. Yaari S, Goldbourt U. A SAS program for evaluating person-years of risk in cohort studies. Camp Biol Med. 1989;19:353-359.
16. Gahlinger PM, Abramson JH. Computer Programs for Epidemiologic Analysis. Honolulu, HI: Makapuu Medical Press; 1993.
17. Cox DR. Regression models and life-tables. J R Stat Soc (Ser B). 1972; 34:187-202.
18. SAS/STAT User's Guide. Version 6. 4th ed. Cary, NC: SAS Institute Inc;. 1987;1:943 and 1987;2:620.
19. Epstein L, Rishpon S, Bental E, Brook Y, Tamir A, Gross B, Szwarc M, Manalis Pillar T. Incidence, mortality, and case-fatality rate of stroke in northern Israel. Stroke. 1989;20:725-729.
20. Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ. 1991;303: 560-564.
21. Goldbourt U. Differences in frequency of atherosclerosis and coronary heart disease between populations and ethnic groups. In: Goldbourt U. de Faire U, Berg K, eds. Genetic Factors in Coronary Heart Disease. Dordrecht, Netherlands: Kluwer Academic Publishers; 1994:3-20.
22. Goldbourt U, Neufeld HN. Genetic aspects of atherosclerosis. Arteriosclerosis. 1986;6:357-377.
23. Yablonski M, Behar A, Ungar H, Resch J, Alter M. Cerebral atherosclerosis among Israeli Jews of European and Afro-Asian origin. Neurology. 1968;18:550-558.
24. Shatenstein B, Kark JD. Mortality in two Jewish populations: Montreal and Israel: environmental determinants of differences. Int J Epidemiol. 1995;24:730-739.
25. Wolf PA, Cobb JL, D'Agostino RB. Epidemiology of stroke. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke: Pathophysiology, Diagnosis and Management. 2nd ed. New York, NY: Churchill Livingstone; 1992:3-27.
26. Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton D, Feinberg WM, Goldstein LB, Gorelick PB, Howard G, Kittner SJ, Manolio TA, Whisnant JP, Wolf PA. American Heart Association Prevention Conference IV: prevention and rehabilitation of stroke: risk factors. Stroke. 1997;28:1507-1517.
27. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22: 312-318.
28. Kannel WB, Cobb J. Left ventricular hypertrophy and mortality: results from the Framingham study. Cardiology. 1992;81:291-298.
29. Roman MJ, Pickering TG, Schwanz JE, Pini R, Devereux RB. Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol. 1995;25:83-90.
30. Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials. JAMA. 1997;278:313-321.
31. Tanne D, Yaari S, Goldbourt U. High density lipoprotein and risk of ischemic stroke mortality: a 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke. 1997;28:83-87.
32. Iso H, Jacobs DR, Goldman L. Accuracy of death certificate diagnosis of intracranial hemorrhage and ischemic stroke. Am J Epidemiol. 1990; 132: 993-998.